Search





Search





Markets
/
Stocks
/
urgn
/

Urogen Pharma Ltd

URGN

Add to Watchlist

38.240USD

-2.850-6.94%

Close 07-31 16:00（ET）Quotes delayed by 15 min

1.86BMarket Cap

LossP/E TTM

Urogen Pharma Ltd

38.240

-2.850-6.94%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

10.00

Change

The current institutional shareholding score of Urogen Pharma Ltd is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 95.00%, representing a quarter-over-quarter decrease of 7.96%. The largest institutional shareholder is Catherine Wood, holding a total of 70.92K shares, representing 0.24% of shares outstanding, with 1.18% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

RTW Investments L.P.

4.54M

Paradigm BioCapital Advisors LP

4.22M

+80.79%

Morgan Stanley & Co. LLC

2.46M

+66.65%

Jefferies LLC

2.20M

BlackRock Institutional Trust Company, N.A.

2.14M

+1.60%

SilverArc Capital Management, LLC

1.58M

-22.01%

SG Americas Securities, L.L.C.

1.16M

+0.72%

Acorn Capital Advisors, LLC

1.26M

American Century Investment Management, Inc.

1.36M

+189678.21%

UBS Asset Management Switzerland AG

1.32M